22157.jpg
North America Obesity Intervention Devices (Gastric Bands, Gastric Balloon, Gastric Stimulation System) Market Size, Share & Industry Trends Analysis Report 2023-2029
23 août 2023 04h28 HE | Research and Markets
Dublin, Aug. 23, 2023 (GLOBE NEWSWIRE) -- The "North America Obesity Intervention Devices Market Size, Share & Industry Trends Analysis Report By End User (Hospitals and Clinics & Others),...
22157.jpg
Worldwide Gastric Balloons and Bands Industry to 2027 - Technological Advancements in Devices and Procedures Presents Opportunities
13 août 2021 07h58 HE | Research and Markets
Dublin, Aug. 13, 2021 (GLOBE NEWSWIRE) -- The "Gastric Balloons and Bands Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027" report has been added to...
22157.jpg
Worldwide Bariatric Surgery Devices Industry to 2026 - Featuring GI Dynamics, Covidien and Allergan Among Others
16 juil. 2021 05h13 HE | Research and Markets
Dublin, July 16, 2021 (GLOBE NEWSWIRE) -- The "Bariatric Surgery Devices Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2026" report has been added to...
22157.jpg
Insights on the Bariatric Surgery Global Market to 2025 - by Service/Device Type, End-user and Region
29 avr. 2021 06h13 HE | Research and Markets
Dublin, April 29, 2021 (GLOBE NEWSWIRE) -- The "Bariatric Surgery: Global Markets for Services and Devices 2020-2025" report has been added to ResearchAndMarkets.com's offering. This report aims...
22157.jpg
Worldwide Intragastric Balloon Market to 2026 - Industry Analysis and Forecast
28 sept. 2020 06h49 HE | Research and Markets
Dublin, Sept. 28, 2020 (GLOBE NEWSWIRE) -- The "Global Intragastric Balloon Market By Administration, By Type, By Filling Material, By End Use, By Region, Industry Analysis and Forecast, 2020 -...
Obalon_Logo_Teal_2c.jpg
Obalon Announces Consulting Agreement As Part of Strategy To Seek Coverage and Reimbursement for The Obalon Balloon System
13 août 2020 07h00 HE | Obalon Therapeutics, Inc.
SAN DIEGO, Aug. 13, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (Nasdaq: OBLN), a weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric...
Obalon_Logo_Teal_2c.jpg
Obalon Announces First Quarter 2020 Financial Results and Business Update
19 juin 2020 06h15 HE | Obalon Therapeutics, Inc.
SAN DIEGO, June 19, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (Nasdaq: OBLN), a weight loss solutions company with the first and only FDA-approved swallowable, gas-filled intragastric...
Obalon_Logo_Teal_2c.jpg
Obalon Announces Further Impacts Related To Covid-19 Crisis and Current Business Environment
11 mai 2020 08h30 HE | Obalon Therapeutics, Inc.
SAN DIEGO, May 11, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (“Obalon” or the “Company”) (NASDAQ:OBLN), a vertically integrated weight loss solutions company commercializing the first and...
Obalon_Logo_Teal_2c.jpg
William Plovanic Resigns as President and Chief Executive Officer and Will Continue to Serve Solely as Director
08 mai 2020 08h00 HE | Obalon Therapeutics, Inc.
SAN DIEGO, May 08, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated weight loss solutions company commercializing the first and only FDA-approved...
Obalon_Logo_Teal_2c.jpg
Obalon Gas-Filled Balloon Not Subject of Fourth FDA Letter to Health Care Providers Related To Serious Risks, Including Death, With Liquid-Filled Intragastric Balloons
28 avr. 2020 09h00 HE | Obalon Therapeutics, Inc.
SAN DIEGO, April 28, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...